Pediatrix Medical Group, Inc.
MD- Exchange
- NYSE
- Industry
- Services-Hospitals
- SEC CIK
- 0000893949
No open-market purchases or sales by Pediatrix Medical Group, Inc. insiders were filed in the last 90 days; 306 institutions reported holding it in 13F filings for Q2 2026, worth $2.12B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $2.47B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +11 vs. previous quarter
- 306
- 13F valueReported value at the end of Q2 2026
- $2.12B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $1.91B
- −4.9% year over year
- Net income, FY2025
- $165.4M
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- $501.4M
- +1.7% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 3.55M
- Shares sold short
- Change
- −824.9K
- −18.9% vs. previous
- Days to cover
- 5.03
- At average daily volume
Superinvestors holding MD, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding MD at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Pediatrix Medical Group, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 (view filing) | May 13 | 1 day | Weis Shirley ADirector | SSale | −36.0K | $23.75 | −$855.7K | −100.0%0 after | |
| Dec 17, 2025 (view filing) | Dec 15 | 2 days | Ordan Mark SChief Executive Officer | SSale | −23.0K | $22.41 | −$515.4K | −7.1%302.8K after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Rucker Michael A.Director | SSale | −10.5K | $23.00 | −$241.0K | −15.1%59.1K after | |
| Nov 10, 2025 (view filing) | Nov 6 | 4 days | Linynsky Laura ADirector | SSale | −10.0K | $21.65 | −$216.5K | −23.7%32.2K after | |
| Nov 14, 2024 (view filing) | Nov 13 | 1 day | Ordan Mark SDirector | SSale | −27.6K | $15.35 | −$423.7K | −16.6%138.7K after | |
| Nov 12, 2024 (view filing) | Nov 8 | 4 days | Moore Mary Ann EEVP, GC, Chief Admin Off & Sec | SSale | −8.11K | $16.00 | −$129.7K | −5.6%135.8K after | |
| Sep 3, 2024 (view filing) | Aug 30 | 4 days | Swift James DChief Executive Officer | SSale | −11.1K | $10.79 | −$119.8K | −6.1%170.0K after | |
| Aug 29, 2024 (view filing) | Aug 27 | 2 days | Linynsky Laura ADirector | SSale | −7.00K | $11.16 | −$78.1K | −18.5%30.8K after | |
| Aug 13, 2024 (view filing) | Aug 9-12 | 4 days | Richards C MarcEVP, Chief Financial Officer | SSale | −50.0K | $10.08 | −$504.0K | −22.2%175.3K after | 2 lots |
| Dec 15, 2023 (view filing) | Dec 14 | 1 day | Moore Mary Ann EEVP, General Counsel & Sec | SSale | −1.15K | $9.62 | −$11.1K | −6.8%15.7K after |
Top 10 13F holders, Q2 2026
See all 306 holdersThe largest institutional positions in Pediatrix Medical Group, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,714,275 | $347.4M | 0.01% | +139,902+1.0% | Added |
| Vanguard Portfolio Management LLC | 5,985,147 | $151.6M | 0.01% | −168,979−2.7% | Reduced |
| Dimensional Fund Advisors LP | 4,220,311 | $106.9M | 0.02% | +363,396+9.4% | Added |
| Vanguard Capital Management LLC | 3,620,040 | $91.7M | 0.00% | −36,281−1.0% | Reduced |
| State Street Corp | 3,533,248 | $89.5M | 0.00% | +154,748+4.6% | Added |
| Victory Capital Management Inc | 3,416,913 | $86.6M | 0.05% | −425,020−11.1% | Reduced |
| Wasatch Advisors Inc | 2,498,884 | $63.3M | 0.41% | +448,360+21.9% | Added |
| Geode Capital Management, LLC | 2,226,028 | $56.4M | 0.00% | +38,061+1.7% | Added |
| American Century Companies Inc | 2,192,017 | $55.5M | 0.02% | −1,733,349−44.2% | Reduced |
| Fuller & Thaler Asset Management, Inc. | 1,721,451 | $43.6M | 0.12% | +492,020+40.0% | Added |
Holders of 5% or more of MD
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Pediatrix Medical Group, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 14.60%12.5M shares | – | Jul 17, 20251 filing | Jul 17, 2025 | SEC |
| Vanguard Portfolio Management LLC | 13G | 7.55%6.28M shares | New | Sep 3, 20261 filing | Sep 3, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.15%4.28M shares | New | Sep 3, 20261 filing | Sep 3, 2026 | SEC |
| Dimensional Fund Advisors LP | 13G | 5.10%4.22M shares | – | Feb 12, 20214 filings | Jul 14, 2026 | SEC |
Politician trades
All politician trades in MD1 member of Congress reported 1 trade in Pediatrix Medical Group, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Apr 27, 2020 |  Donna E. Shalala House · FL | Sell | $50K-$100K |
House · FL · Apr 27, 2020
Sell$50K-$100K